Context: There is little information on the long-term natural history of Silver-Russell syndrome (SRS).
of maternal 11p15 material (3, 4) . In a substantial proportion of patients (40%), the molecular cause remains unknown, and SRS remains primarily a clinical diagnosis based on the Netchine-Harbison (NH) scoring system (2, 5) . Indeed, a targeted next-generation sequencing approach in patients referred for SRS testing increases the mutation rate as well as other diagnoses overlapping SRS (6) (7) (8) (9) .
The management of children with SRS requires a multidisciplinary approach. Specific issues include body asymmetry, failure to thrive and growth failure, severe feeding difficulties, gastrointestinal problems, hypoglycemia, motor and speech delay, and psychosocial challenges (2) . Indeed, there is little information on the long-term natural history of SRS, changes in clinical phenotype, and metabolic consequences in adulthood (10) (11) (12) (13) . On the other hand, it is well recognized that being small for gestational age (SGA) at birth increases the risk for metabolic concerns in adulthood (12, 14) . Hypertension, dilated cardiomyopathy, and type 2 diabetes mellitus have been reported in a few cases (10) (11) (12) (13) .
Here, we report the phenotypes and the metabolic assessment of seven adult Italian patients with a clinical diagnosis of SRS, confirmed by molecular genetic analysis.
Methods
The study group comprised seven patients with a mean age [6 standard deviation (SD)] of 26.9 6 9.1 years (range, 18 to 46 years) who were voluntarily recruited by the Italian Association of Silver Russell Syndrome (AISRS Onlus).
Birth data were obtained from available hospital records. Clinical score was evaluated according to the NH scoring system (2) . According to the latter, macrocephaly was defined as an occipital-frontal circumference $ 1.5 SD above weight and/ or height (2, 5) . Each patient was examined by the same two pediatric endocrinologists (G.P. and N.D.) with experience in the field of SRS. Height was measured to the nearest 0.1 cm (Harpenden stadiometer), weight to the nearest 0.1 kg (TANITA Corporation, Tokyo, Japan). Waist circumference was evaluated midway between the lower margin of the lowest rib and the upper margin of the iliac crest at the end of a normal expiration. A standard 2-hour oral glucose tolerance test was administered by using a 1.75-g/kg glucose load. Bone mineral density (BMD; lumbar spine at L1 to L4, total body, femoral neck), lean body mass (LBM, in kg), and fat body mass expressed as percentage, fat mass index (FMI, in kg/m 2 ) and trunk fat/limb fat ratio were measured by dual-energy x-ray absorptiometry (DXA; Lunar Prodigy, version 13, GE Healthcare, Madison, WI). Quality control was performed daily. Data for body composition were compared with published normative data (15, 16) .
To compare our patients with short healthy controls, we examined the body composition data for the shortest healthy young adults (six males and five females; mean age, 17 years) available in our DXA institutional database (mean height, 151.6 6 3.3 cm in females and 159.8 6 2.4 cm in males).
After 15 minutes of rest, diastolic and systolic blood pressure were measured in the sitting position, using the nondominant arm, with an automatic device (Carescape, Dinamap technology Vital Signs 100, GE Healthcare). Fasting levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, and triglycerides were measured by using a homogeneous enzymatic colorimetric assay (Roche, Milan, Italy). Bone-specific alkaline phosphatase cross-linked carboxy-terminal telopeptide of type 1 collagen were analyzed by using two enzyme-linked immunosorbent assay (ELISA) kits (METRA BAP ELISA kit; Quidel Corp., San Diego, CA) and (Serum Crosslaps; Immunodiagnostics System, Frankfurt, Germany) both automatized on a DSX automated ELISA processing system (Dynex Technologies; Technogenetics, Milan, Italy). Vitamin 25(OH) D (ng/mL) and parathyroid hormone (pg/mL) were determined by using chemiluminescence (Roche); adiponectin (ng/dL) was measured by using an ELISA kit (total human adiponectin ELISA; Teco Medical Group, Sissach, Switzerland) on a DSX automated ELISA processing system (Dynex Technologies; Technogenetics). Hormonal parameters were evaluated by chemiluminescent assay (Roche). Criteria for metabolic syndrome were defined according to the National Cholesterol Education Program (17) in presence of at least three of the following risk factors: waist circumference $ 88 cm in women and $ 102 cm in men; triglycerides $ 150 mg/dL; HDL cholesterol , 50 mg/dL in women and , 40 mg/dL in men; fasting glucose $ 100 mg/dL; systolic blood pressure $ 130 mm Hg or diastolic blood pressure $ 85 mm Hg.
Written informed consent was obtained from all participants, and permission was authorized for the publication of their photographs.
Patients

Patient 1
This female patient was born to healthy parents and was normally delivered at 39 weeks of gestation. Birth weight was 2500 g (21.76 SD) (18) , length was 46 cm (21.77 SD), and occipito-frontal circumference was 35 cm (+0.96 SD). Because of growth impairment, feeding difficulty, and poor weight gain with distinctive craniofacial features (Fig. 1) , SRS was hypothesized at the age of 3 months. Molecular analysis revealed mUPD7. Her development was normal, and she met all developmental milestones at the appropriate times. During childhood, she had a dental brace tailored because of crowded teeth, and she experienced tics during school age. Because her height was always above 22.5 SD (19) (22.1 SD from 2 to 6 years and 21.9 from 7 to 9 years according to available measurements obtained from clinical records), no growth hormone (GH) therapy was started. She experienced menarche at 13 years of age, with a subsequently regular menstrual cycle.
At age 21 years, she is a medical student, has a good social life, and practices ballet three times a week. Last examination revealed a weight of 38. Table 1) . A slightly triangular face and a prominent forehead were evident; she has micrognathia and comparatively large teeth. She also has clinodactyly of her fifth finger and wears glasses owing to myopia.
Patient 2
This male patient was a second child, born after 38 weeks of gestation via vaginal delivery. His birth weight was 2000 g (23.0 SD), birth length was 43 cm (23.15 SD), and occipital-frontal circumference was 33 cm (21.2 SD).
He displayed failure to thrive and feeding difficulties since the first months of life, leading to nutritional support via a nasogastric tube until age 8 years. At age 2 years, he had an episode of symptomatic fasting hypoglycemia. He had a mild motor delay and was not able to walk alone until 2.5 years of age.
His cognitive development was good, and he never had any difficulties at school. He obtained a diploma as a qualified accountant. He has a busy social life, enjoys relatively good health, and works as a municipal employee. At the last evaluation, at 27 years of age, his height was 150.9 cm (23. head occipital-frontal circumference of 57.3 cm (+2.3 SD). He had normal pubertal development with a bilateral testicular volume of 15 mL. He also had clinodactyly of the fifth finger, and no body asymmetry was observed. He has experienced excessive sweating since the first months of life. Molecular tests revealed mUPD7.
Patient 3
This female patient was born at 39 weeks of gestation. Her birth weight was 1850 g (23.2 SD), birth length was 40 cm (24.2 SD), and occipital-frontal circumference was 34 cm (+0.12 SD), with relative macrocephaly. In her first years of life, she displayed feeding difficulties and failure to thrive. From age 6 years onward, however, she has been overweight. She had menarche at age 11 years, followed by regular menses. She also displayed chronic otitis media in childhood and cholesteatoma in the left ear at age 14 years.
At last evaluation at age 25 years, her height was 137.5 cm (24.1 SD), sitting height was 74.7 cm (24.2 SD)-with a sitting height/height ratio of 0.54 (+1 SD)-and weight was 61 kg, with a BMI of 32.3 kg/m 2 (+2.5 SD). She also had relative macrocephaly, with an occipital-frontal circumference of 52.5 cm (21.2 SD), fifth-finger clinodactyly, and body asymmetry (leg length discrepancy of 1.5 cm; arm and facial asymmetry). Her facial appearance is shown in Fig. 2 . Her neuropsychological development was normal, and she recently graduated as a social worker. Molecular tests were performed at age 24 years and showed 11p15 LOM.
Patient 4
After an uncomplicated pregnancy, this female patient was born in 1970 after 41 weeks of gestation by natural delivery and had a birth weight of 2300 g (22.7 SD). Data on length and occipito-frontal circumference, as well as on clinical outcome at birth, are lacking. However, her parents reported that she was born SGA in terms of both weight and length and had relative macrocephaly.
In the first months of life, she had feeding difficulties and failure to thrive. Her cognitive development was normal. As a child, she enjoyed relatively good health. Since leaving school, she has worked as a post office employee. At age 40 years, she had a son, who is currently 6 years old and in good health. Her pregnancy was characterized by cervical incompetence. She experienced menopause at age 44 years. The patient has experienced significant dental overcrowding and misalignment, requiring orthodontic treatment and multiple tooth extractions. Methylation study revealed 11p15 LOM.
At the time of examination, the patient was 46 years old and 149.5 cm tall (22.1 SD). Her BMI was 23 kg/m 2 (+0.3 SD), and her occipito-frontal circumference was 53.5 cm (20.5 SD) ( Table 1 ). She had leg length and arm asymmetry. She reports eating normalsized adult portions and having difficulty maintaining her weight.
Patient 5
This female patient was born to healthy nonconsanguineous parents at 40 weeks of gestational age. Her birth weight was 1850 g (23.5 SD), her birth length was 40 cm (24.6 SD), and relative macrocephaly was documented at birth. Poor fetal growth was first noted in the 30th week of gestation.
She had severe feeding difficulties during the first years of life. However, a nasogastric tube for feeding was not inserted. Because of her short stature, GH therapy was started when she was age 7 years and was continued until she was age 9 years. She experienced precocious puberty with menarche at age 9 years, and gonadotropinreleasing hormone analog treatment was performed from age 9 to 10 years.
She had significant dental overcrowding and misalignment, which led to orthodontic treatment and multiple teeth extractions. Micrognathia was also pronounced. She graduated with a degree in sports science and is now working in a call center as an operator. She had a miscarriage at 10 weeks of pregnancy at age 29 years. Molecular analysis performed at age 24 years showed 11p15 LOM. At the last evaluation, at age 29 years, her height was 136.7 cm (24.3 SD), her BMI was 18.2 kg/m 2 (21.7 SD), she had persistent relative macrocephaly, and her head circumference was +0.5 SD (Table 1) . She had leg length, foot, and facial asymmetry.
Patient 6
This male patient was prematurely born at the 31st gestational week via cesarean delivery due to intrauterine growth restriction (IUGR), oligohydramnios, and fetal distress. At birth, he was SGA and displayed relative macrocephaly and the typical clinical manifestations of SRS, including a prominent forehead, a triangular face, low-set ears, and fifth-digit clinodactyly. No body asymmetry was observed. Developmental milestones were delayed (he walked at 2.5 years of age and pronounced his first words at 3 years of age). Molecular analysis showed a maternally inherited duplication of chromosome 11p15. GH therapy was started at age 7 years and was withdrawn at age 11 years because of glucose intolerance. He currently displays selective mutism and mild cognitive delay, and he is assisted by a teaching-support specialist. On last physical examination at age 18 years, his height was 141.2 cm (25 SD), weight was 42.5 kg, BMI was 21.3 kg/m 2 (0 SD), and occipito-frontal circumference was 56.5 cm (+1.4 SD) ( Table 1) . He wears glasses because of astigmatism.
Patient 7
This female patient was born prematurely (at 32 weeks of gestational age) by cesarean delivery. Her birth weight was 950 g (22.2 SD). Although her birth length and occipito-frontal circumference were not available, a measurement compatible with macrocephaly was reported at ages 1 to 3 years. She had menarche at age 11 years, followed by regular menses.
She has an ectopic kidney, incidentally detected by abdominal ultrasonography. She has had two pregnancies characterized by cervical incompetence: In the 28th week of her first pregnancy, she delivered a stillborn baby; in her second pregnancy she delivered in the 24th week, and the baby died after a few hours. Molecular tests performed in adulthood revealed a duplication of chromosome 11. Current examination, at age 23 years, revealed a weight of 43.5 kg, height of 145.3 cm (22.8 SD), BMI of 20.6 kg/m 2 (-0.6 SD), and an occipito-frontal circumference of 51.5 cm (21.9 SD) ( Table 1) .
Results
NH clinical score
The clinical diagnosis was confirmed by molecular genetic analysis: three patients had 11p15 LOM, two had mUPD7, and two had 11p15 duplication.
Clinical characteristics and body composition of the patients are listed in Table 1 . All patients but one were born SGA (mean birth weight, 22.76 SD 6 0.6; mean birth length, 23.43 SD 6 1.2). Body asymmetry was found in patients with 11p15 LOM (patients 3, 4, and 5) ( Table 2) .
At the time of diagnosis, all patients showed typical facial features of SRS: frontal bosses, relative macrocephaly, triangular facies, and micrognathia. Mean adult height was 23.3 SD 6 1.2, and only two patients (patients 5 and 6) received short-term GH therapy. One patient (patient 5) developed precocious puberty. Two women (patients 4 and 7) who had a pregnancy had cervical incompetence requiring cerclage. The NH clinical score declined in all but two of the seven patients during adulthood (Table 2) . Two patients (patients 1 and 2), both mUPD7, were still underweight, four patients had a normal BMI, and one was obese; patient 6 had a cognitive delay. All patients but one displayed relative macrocephaly in adulthood. 
Metabolic and body composition findings
Oral glucose tolerance testing showed glucose intolerance and hyperinsulinemia in two patients (Table 3) . Two patients (patients 2 and 4) showed high total cholesterol levels with low HDL cholesterol levels. The obese patient (patient 3) had high waist/hip and waist/height ratios (21, 22) . All patients showed normal triglyceride levels and blood pressure (23) ( (15, 16) (Table 1 ). The trunk/limb fat ratio did not correlate with different measures of adiposity (BMI SD, FMI, fat body mass percentage); however, it showed an inverse relation with HDL cholesterol levels (r = 20.78; P = 0.036) and a trend toward a direct relation with glucose 120' (r = 0.67; P = 0.11).
FMI was significantly higher in patients (P = 0.004) than in short healthy controls (9.1 6 5.2 kg/m 2 vs. 6.0 6 0.6 kg/m 2 in females, respectively; 6.6 6 1.4 kg/m 2 vs.
4.5 6 1.4 kg/m 2 in males, respectively). In addition, the patients with SRS showed mean trunk fat significantly higher than that in healthy controls: 8.1 6 4.7 kg vs. 6.0 6 0.5 kg in females, respectively, and 7.7 6 0.2 kg vs. 5.5 6 1.9 kg in males, respectively. The latter findings suggest that both female and male patients with SRS have almost 2 kg more trunk fat than do controls. This represents a further 35% of the truncal fat mass in female patients with SRS and 41% more in male patients with SRS compared with controls. Lean mass index (LMI) showed a trend toward lower values in patients with SRS (P = 0.07), with an LMI of 12.0 6 1.0 kg/m 2 in female patients with SRS compared with 12.2 6 0.5 kg /m 2 in controls and LMI of 12.7 6 0.5 kg/m 2 in male patients with SRS with 14.9 6 1.5 kg/m 2 in controls.
Discussion
Few long-term follow-up studies have been conducted in patients with SRS, and the clinical phenotype as well as the metabolic outcomes of this condition during adulthood remain to be defined (12, 24) . Although several studies have shown that children who are SGA at birth are prone to later development of metabolic disorders, including insulin resistance and diabetes, hypercholesterolemia, and cardiovascular diseases (14, 25) , little has been reported in patients with SRS, who are generally born SGA and as having IUGR. Here, we report the clinical features and the metabolic profiles of seven adult patients with a molecular diagnosis of SRS, re-evaluated at a mean age of 26.9 6 9.1 years. The diagnosis of SRS at birth or during childhood could be straightforward based on validated clinical criteria (5), recently highlighted by the first international consensus statement (2) . Nevertheless, SRS is a heterogeneous condition, and its differential diagnosis could be a challenge already in children presenting with IUGR, in which the underlying molecular abnormalities could not be confirmed (2, 6, 7, 9) , or in those born appropriate for gestational age with mUPD7 (26, 27) . Therefore, the diagnosis of missed SRS or SRS-like conditions may be even more difficult in adults.
Because the criteria and scores for the diagnosis of SRS were validated for patients aged 1.05 to 20.06 years, with a mean age of 6.61 years (5), we asked whether the clinical characteristics of these patients could be maintained over time and specifically after age 20 years. It is worth pointing out, however, that the clinical features of relative macrocephaly, protruding forehead (although less pronounced), and body asymmetry were maintained after 20 years, suggesting that their identification in an adult born SGA or with IUGR with an adult height of less than 22 SD should prompt physicians to consider a missed diagnosis of SRS during childhood. In adults suspected of having SRS, it is also advisable to check for early-childhood photographs. Indeed, feeding difficulties and low BMI did not appear to be typical features of adults with SRS but were consistently present during the first year of life. However, the BMI of most of these patients remained between 22.8 to 0 SD, except for one patient with severe obesity, who showed high waist/hip and waist/height ratios, risk factors for cardiovascular disease (21, 22) . It is known that patients born SGA are at risk for insulin resistance and cardiovascular disease, which seems to be related to the rate of weight gain occurring during the first years of life and to the adverse prenatal metabolic environment (25, 28) . In addition to adult weight, weight catch-up growth during childhood is a strong determinant of body composition, and patients with SGA and catch-up growth have been reported to have significantly higher fat mass percentage % and lower LBM than controls (28) . Our patients displayed a low LBM and a high fat mass percentage, FMI, trunk fat percentage, and trunk fat/limb ratio (the latter being a surrogate of central adiposity) compared with a small group of short controls, suggesting that patients with SRS have an abnormal body composition. Thus, total and visceral fat mass should be adequately defined in patients with SRS as compared with healthy controls (15, 16) , where BMI and waist circumference are commonly included in the definition of the cardiovascular risk profile (17, 29) , and raise the question about the role of DXA values in the assessment of the cardiovascular risks in adults with SRS.
To our knowledge, there are only two case reports and one long-term study addressing metabolic health in SRS (10) (11) (12) . In particular, a 69-year-old man originally reported by Russell in 1953, is the oldest patient with SRS ever reported (11, 30) . The patient enjoyed a relatively good life, was married, and had a daughter. He had hypercholesterolemia, developed type 2 diabetes mellitus at age 56 years, and developed osteopenia and hypogonadotropic hypogonadism later in life (11) . Takenouchi et al. (10) described three young adults with SRS (early 20s) with 11p15 LOM who developed type 2 diabetes, hyperlipidemia, and hypertension, respectively. In addition, the recent long-term study available on metabolic status of patients with SRS showed no metabolic differences between patients treated with GH and SGA patients without SRS before, during, and through 2 years after the discontinuation of GH; none of the patients with SRS developed diabetes or metabolic syndrome at the mean age of 18 years (12).
Our findings of glucose intolerance and hyperinsulinemia in two patients at ages 18 and 27 years, respectively, suggests that these patients can develop early abnormalities in glucose metabolism. In addition, although glucose intolerance and hypercholesterolemia were found to be independent of BMI, FMI, total percentage body fat, and molecular findings, both HDL cholesterol level and glucose intolerance were related to the trunk/limb fat ratio. Regarding BMD, DXA examination of these adults with SRS, performed for the first time at three skeletal sites (spine, femur, and total body), showed normal bone mineralization. These findings deserve further follow-up because DXA technique may underestimate bone mass in short/small persons. Hence, limitations of our study include the small number of patients and their relatively young age.
In conclusion, the recognition of SRS features after achievement of adult height is crucial for the identification of patients with classical phenotype in order to establish a real prevalence of this rare condition; it is essential for genetic counseling, and it enables these patients to benefit from the early management of their metabolic complications. Although the scoring system for the diagnosis of SRS has been validated for children and adolescents, the diagnosis of SRS seems to also be reliable in adults; however, some clinical signs may become less pronounced with age, suggesting the need for further validation. The increase in central adiposity detected by DXA deserves further studies, and long-term follow-up in a larger number of patients with SRS is mandatory to understand the natural history of this disease and improve the management of these patients.
